Saturday 17 October 2026
Export SENS’s income statement to Excel — free account
Senseonics Holdings, Inc.
SENS Healthcare Medical Devices
Senseonics Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $35.3 million, up 56.9% from fiscal 2024. In the quarter to June 2026, revenue grew 117.8%, EPS fell 57.5%, free cash flow fell 223.2% and total debt rose 58.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
7.85
0.38
−4.62%
Follow SENS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 5 | 3 | 3 |
| (209.12%) | (310.68%) | (250.78%) | (118.24%) | ||
| (53.98%) | (60.97%) | (91.74%) | (66.88%) | ||
ROIC |
(1,781.48%) | (1,867.54%) | (965.68%) | (2,152.05%) | |
Return on Tangible Assets |
(55.83%) | (70.97%) | (124.37%) | (74.88%) | |
Average Days of Receivables |
89.65 | 125.46 | 131.89 | 77.21 | |
Free Cash Flow per Share |
(1.25) | (1.44) | (1.66) | (1.67) | |
Free Cash Flow |
(56.17) | (60.24) | (75.87) | (96.83) | |
Capital Expenditures |
(0.76) | (1.12) | (0.79) | (0.89) | |
| Other line items | |||||
Cash ROIC |
(25.00%) | (31.55%) | (56.25%) | (33.49%) | |
Accounts Receivable Turnover |
5.22 | 3.83 | 4.23 | 6.29 | |
Accounts Payable Turnover |
4.29 | 5.37 | 7.51 | 6.18 | |
Inventory Turnover |
3.62 | 3.50 | 3.04 | 3.33 | |
Average Days of Payables |
125.50 | 76.00 | 59.63 | 80.37 | |
Days of Inventory on Hand |
133.77 | 125.51 | 155.41 | 140.91 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
109.68% | 89.60% | 80.82% | 75.86% | |
Selling, General and Administrative Expense of Revenue |
141.97% | 148.93% | 184.20% | 202.22% | |
Share Based Compensation of Revenue |
32.74% | 28.80% | 26.01% | 23.21% | |
Interest Coverage |
(10.42) | (13.80) | (18.39) | (20.96) | |
Operating CF/Net income |
0.87 | 0.86 | 0.86 | 0.88 | |
Depreciation/Fixed assets |
0.47 | 0.36 | 0.40 | 0.43 | |
Capex/Depreciation |
(0.40) | (0.74) | (0.47) | (0.48) | |
Revenue per Share |
0.65 | 0.84 | 0.89 | 0.84 | |
Operating CF per Share |
(1.23) | (1.42) | (1.64) | (1.66) | |
Capex per Share |
(0.02) | (0.03) | (0.02) | (0.02) | |
Capex to Sales |
0.03 | 0.03 | 0.02 | 0.02 |
Columns are period end dates